New trial
Micro-US vs MRI in Active Surveillance for Detecting ≥GG2 Prostate Cancer
- Trial ID
- NCT05558241 on ClinicalTrials.gov
- Cancer type
- Prostate Cancer
- Location
- 4 Locations
- Published in
- New in Oncology - June 6, 2025
University of Alberta is conducting the MUSIC-AS trial to compare micro-ultrasound–guided biopsies (using the UTZ Imaging System) with MRI-guided methods in active surveillance of Gleason Grade Group 1 prostate cancer. This study evaluates the accuracy of detecting clinically significant (≥GG2) disease via targeted sampling combined with a standard 12-core biopsy and collects blood for future biomarker research.
More in prostate cancer
-
Trial result · Oct 22, 2026 · NCT03732820
Olaparib (PARP inhibitor) + Abiraterone (CYP17 AR-pathway inhibitor) Extends rPFS in Non‑BRCA mCRPC (PROpel) -
New trial · Oct 15, 2026 · NCT07813637
Phase 1 JANX013 PSMA×CD28 costimulation combines with JANX007 PSMA×CD3 T-cell engagement -
New trial · Oct 15, 2026 · NCT07832292
Phase 2 JNJ-101556143 uses an AR-BRD4 induced-proximity mechanism in resistant prostate cancer -
New trial · Oct 8, 2026 · NCT07824349
Phase 1a/1b JUR-003 KLK2×CD3 bispecific T‑cell engager in metastatic prostate cancer -
New trial · Oct 1, 2026 · NCT07803653
Phase 1 FH-STEAP1 IL-18 CAR T tests STEAP1-targeted CAR-T armored with IL-18
